This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Arizona. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Matthew Kaplan: Innovator in SARS-CoV-2 Testing
Introduction
Matthew Kaplan is an accomplished inventor based in Tucson, AZ (US). He has made significant contributions to the field of medical diagnostics, particularly in the context of the COVID-19 pandemic. His innovative work focuses on developing effective testing systems for detecting SARS-CoV-2 antibodies.
Latest Patents
Matthew Kaplan holds a patent for "Serological assays for SARS-CoV-2." This patent describes a test system that includes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain (RBD) antigen, SARS-CoV-2 S2 antigen, and binding moieties that specifically bind to human IgG, human IgA, and human IgM. The patent also outlines methods for detecting SARS-CoV-2 antibodies in a sample using this test system. He has 1 patent to his name.
Career Highlights
Matthew Kaplan is affiliated with The University of Arizona, where he contributes to research and development in the field of virology and immunology. His work has been instrumental in advancing the understanding and detection of COVID-19.
Collaborations
Some of his notable coworkers include Tyler Ripperger and Ryan Sprissler, who collaborate with him on various research projects related to SARS-CoV-2 testing and diagnostics.
Conclusion
Matthew Kaplan's innovative contributions to SARS-CoV-2 testing exemplify the critical role of inventors in addressing global health challenges. His work not only enhances diagnostic capabilities but also supports public health efforts in combating the COVID-19 pandemic.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile